-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent days, India’s out-of-control epidemic, the collapse of the medical system, lack of oxygen, and the burning of corpses in the street remind us that the new crown epidemic is still not over.
The new crown pneumonia in addition to the direct cause of death, which also affected other pandemic diseases clinic .
New coronary pneumonia diagnosis and treatment The impact of the new coronary pneumonia pandemic on all aspects of the diagnosis and treatment of ST-segment elevation myocardial infarction (STEMI), including timely direct percutaneous coronary intervention (PPCI), myocardial infarction
The latest, published in " J Am Coll Cardiol " on "the From Initial Findings at The North American COVID-19 Myocardial Infarction Registry " study describes infection demographic characteristics of patients with STEMI new crown pneumonia, management strategies and clinical outcomes.
Am Coll Cardiol J " on the Initial Findings" the From at The North American COVID-19 Myocardial Infarction Registry J Am Coll Cardiol "J Am Coll CardiolonInitial Findings" the From at The North American COVID-19 Myocardial Infarction RegistryCOVID-19infectionmanagement
The researchers established a prospective and continuous observational registry based on the guidance of the three cardiology societies, including those who were diagnosed with COVID+ infection (group 1) or suspected of being infected with new coronary pneumonia (PUI, group 2) STEMI patients.
Stroke
As of December 6, 2020, a total of 1185 patients have been enrolled in the NACMI registry (230 COVID+ patients, 495 PUI patients and 460 control patients).
Prognosis of patients in each group
Prognosis of patients in each groupCOVID+ patients are more likely to be ethnic minorities (23% of Hispanics, 24% of blacks), and the prevalence of diabetes is higher (46%) (both P<0.
COVID+ patients are more likely to be ethnic minorities (23% of Hispanics, 24% of blacks), and the prevalence of diabetes is higher (46%) (both P<0.
The main outcome rates of COVID+ patients, PUI patients and control group patients were 36%, 13%, and 5% (compared with control group, P<0.
Full text summary diagram
Full text summary diagramIn summary, in the context of the new coronary pneumonia pandemic, the overall prognosis of STEMI patients infected with new coronary pneumonia is significantly worse .
In the context of the new coronary pneumonia pandemic, the overall prognosis of STEMI patients infected with the new coronary pneumonia is significantly worse.
Original source:
Garcia Santiago, Dehghani Payam, Grines Cindy et al.
org/10.
1016/j.
jacc.
2021.
02.
055" target="_blank" rel="noopener">Initial Findings From the North American COVID-19 Myocardial Infarction Registry Leave a message here
